Purpose: The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational in vitro devices for use in clinical laboratory medicine including oncology, immunology, and allergy and makes appropriate recommendations to the Commissioner of Food and Drugs.
As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.
Current Number of Vacancies: 8
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.
Designated Federal Officer
Aden S. Asefa, MPH
Center for Devices and Radiological Health
Office of Management
Food and Drug Administration10903 New Hampshire Ave.
White Oak Bldg. 66 Rm 5214
Silver Spring, MD 20993
Whitney V. Christian, Ph.D. **
Expertise: Molecular Toxicology
Term: 10/31/2019 – 02/28/2023
Managing Principal Toxicologist
6743 Southpoint Drive North
Jacksonville, FL 32216
* Consumer Representative
** Industry Representative